Cartherics Pty Ltd
Kathy Skoff is an experienced clinical research consultant and drug development expert, currently serving as a Company Director at Prednost Clinical Pty Ltd since January 2018 and as Head of Clinical Operations at Cartherics Pty Ltd since December 2024. With a robust background that includes roles such as Senior Business Development Manager and Clinical Program Manager at Neuroscience Trials Australia from August 2012 to July 2023, and Manager of the Medical and Cognitive Research Unit at Austin Health from October 2014 to March 2019, Kathy has demonstrated leadership in clinical operations across various organizations. Additional positions held include VP of Clinical Operations at Senz Oncology Pty Ltd and Clinical Trial Manager at Verva Pharmaceuticals Ltd. Kathy's educational qualifications comprise a Master of Engineering in Project Management from RMIT University, supplemented by study at La Trobe University.
This person is not in any teams
Cartherics Pty Ltd
Cartherics is a biotechnology company focused on developing innovative cancer therapies. We work to create precisely-defined immunotherapy treatments to combat a variety of cancers. We take a multi-platform approach combining the best components of immune defences utilising gene editing and CAR technology – developing more precise and more accessible treatment options for patients. We are focused on solid tumours and disrupting the tumour microenvironment (TME) to make tumours accessible to immune destruction. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer. We’re developing new forms of solid cancer care treatment - helping patients fight cancer and take back control of their lives.